PSMB9 and breast carcinoma: Intriguingly, all CRLM of patient II (favorable outcome) were characterized by a strikingly high expression of the WNT pathway-related immunoproteasome gene PSMB9, which has been associated with enhanced lymphocyte infiltration and longer survival in breast cancer patients [56].